However, recent studies have shown that SPON2 is upregulated in various carcinomas including colorectal carcinoma, hepatocellular carcinoma, laryngeal squamous cell carcinoma, and gastric cancer, as well as prostate cancer [15,16,17,18]. This evidence concerns the gene SPON2 and gastric cancer.